ALNY icon

Alnylam Pharmaceuticals

449 hedge funds and large institutions have $20.9B invested in Alnylam Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 162 increasing their positions, 162 reducing their positions, and 58 closing their positions.

Holders
449
Holders Change
-23
Holders Change %
-4.87%
% of All Funds
7.16%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
43
Increased
162
Reduced
162
Closed
58
Calls
$172M
Puts
$203M
Net Calls
-$30.3M
Net Calls Change
+$11.9M
Name Market Value Shares Shares
Change
Shares
Change %
Nomura Holdings
476
Nomura Holdings
Japan
-1,572 Closed
Los Angeles Capital Management
477
Los Angeles Capital Management
California
-1,507 Closed
DU
478
Delphia (USA)
Ontario, Canada
-1,490 Closed
MC
479
Machina Capital
France
-1,324 Closed
I
480
InceptionR
California
-1,279 Closed
MF
481
Meridian Financial
Massachusetts
-1,234 Closed
QPBE
482
Quintet Private Bank (Europe)
Luxembourg
-1,217 Closed
VIA
483
Vident Investment Advisory
Georgia
-1,144 Closed
SW
484
SlateStone Wealth
Florida
-1,100 Closed
FSA
485
Fort Sheridan Advisors
Illinois
-1,078 Closed
CGH
486
Crossmark Global Holdings
Texas
-1,062 Closed
Walleye Capital
487
Walleye Capital
New York
-1,040 Closed
QT
488
Quantbot Technologies
New York
-699 Closed
VSQM
489
V-Square Quantitative Management
Illinois
-279 Closed
FGAM
490
Financial Gravity Asset Management
Texas
-190 Closed
BCWM
491
Bartlett & Co Wealth Management
Ohio
-100 Closed
BC
492
Bartlett & Co
Ohio
-100 Closed
EC
493
Elequin Capital
New York
-70 Closed
RTC
494
Riverview Trust Company
Washington
-67 Closed
HF
495
Halpern Financial
Virginia
-45 Closed
FA
496
Fiduciary Alliance
South Carolina
-25 Closed
TFP
497
Tilia Fiduciary Partners
North Carolina
-21 Closed
CFO
498
CVA Family Office
Colorado
-15 Closed
NC
499
NewSquare Capital
Pennsylvania
-10 Closed
TPCW
500
TD Private Client Wealth
New York
-9 Closed